A Sabin 3/Sabin 2/Sabin 3 (S3/2/3) intertypic recombinant poliovirus was isolated from a faecal specimen from a 2-year-old healthy boy approximately 12 weeks after administration of oral poliovirus vaccine. The first recombination junction was in the genomic region encoding the VP1 capsid protein between nucleotide positions 3274 and 3285 (numbering according to Sabin 3) and the second was in the RNA polymerase region (nucleotide positions 6824 and 6825). The recombination had introduced six Sabin 2-derived amino acids into the Sabin 3 capsid environment in the carboxyl terminus of VP1. The complete genome of the recombinant virus differed from corresponding parental Sabin strains at 33 nucleotide positions, nine of them resulting in an amino acid substitution. Four substitutions were in the capsid proteins and five were in the region encoding the non-structural proteins. One amino acid was changed in the antigenic site 2B and two in site 3B. In addition, the whole antigenic site 3A was replaced by Sabin 2-specific amino acids, but the antigenic characteristics of the S3/2/3 did not show type 2-specific features. Neutralizing antibody titres in sera from Finnish children immunized with the inactivated poliovirus vaccine were not lower against the recombinant virus than against Sabin 3. Our results suggest that the chimeric virus was most likely generated by recombination events in the vaccinee, rather than representing progeny of circulating vaccine-derived virus.
BalanantJ.,
GuillotS.,
CandreaA.,
DelpeyrouxF.,
CrainicR.1991; The natural genomic variability of poliovirus analysed by a restriction fragment length polymorphism assay. Virology 184:645–654
BlomqvistS.,
SkyttäA.,
RoivainenM.,
HoviT.1999; Rapid detection of human rhinoviruses in nasopharyngeal aspirates by a microwell reverse transcription-PCR-hybridisation assay. J Clin Microbiol 37:2813–2816
ChumakovK. M.,
NorwoodL. P.,
ParkerM. L.,
DragunskyE. M.,
RanY.,
LevenbookI. S.1992; RNA sequence variants in live poliovirus vaccine and their relation to neurovirulence. J Virol 66:966–970
EvansD. M. A.,
DunnG.,
MinorP. D.,
SchildG. C.,
CannA. J.,
StanwayG.,
AlmondJ. W.,
CurreyK.,
MaizelJ. V.1985; A single nucleotide change in the 5′ non-coding region of the genome of the Sabin type 3 polio vaccine is associated with increased neurovirulence. Nature 314:548–550
GeorgescuM. M.,
DelpeyrouxF.,
Tardy-PanitM.,
BalanantJ.,
CombiescuM.,
CombiescuA. A.,
GuillotS.,
CrainicR.1994; High diversity of polio vaccine strains isolated from the central nervous system of patients with vaccine-associated paralytic poliomyelitis. J Virol 68:8089–8101
GeorgescuM. M.,
DelpeyrouxF.,
CrainicR.1995; Tripartite genome organization of a natural type 2 vaccine/nonvaccine recombinant poliovirus. J Gen Virol 76:2343–2348
HuovilainenA.,
KinnunenL.,
FergusonM.,
HoviT.1988; Antigenic variation among 173 strains of type 3 poliovirus isolated in Finland during the 1984 to 1985 outbreak. J Gen Virol 69:1941–1948
KewO.,
Morris-GlasgowV.,
LandaverdeM.21 other authors2002; Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296:356–359
KilpatrickD. R.,
NottayB.,
YangC.,
YangS.,
MuldersM. N.,
HollowayB.,
PallanschM. A.,
KewO. M.1996; Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residues at positions of codon degeneracy. J Clin Microbiol 34:2990–2996
LiuH. M.,
ZhengD. P.,
ZhangL. B.,
ObersteM. S.,
PallanschM. A.,
KewO. M.2000; Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China. J Virol 74:11153–11161
MacadamA. J.,
ArnoldC.,
HowlettJ.9 other authors1989; Reversion of the attenuated and temperature-sensitive phenotypes of the sabin type 3 strain of poliovirus in vaccinees. Virology 172:408–414
MinorP. D.,
DunnG.1988; The effect of sequences in the 5′ non-coding region on the replication of polioviruses in the human gut. J Gen Virol 69:1091–1096
MinorP. D.,
FergusonM.,
EvansD. M. A.,
AlmondJ. W.,
IcenogleJ. P.1986; Antigenic structure of polioviruses of serotypes 1, 2 and 3. J Gen Virol 67:1283–1291
MinorP. D.,
DunnG.,
EvansD. M. A.8 other authors1989; The temperature sensitivity of the Sabin type 3 vaccine strain of poliovirus: molecular and structural effects of a mutation in the capsid protein VP3. J Gen Virol 70:1117–1123
MuldersM. N.,
LipskayaG. Y.,
van der AvoortH. G.,
KoopmansM. P.,
KewO. M.,
van LoonA. M.1995; Molecular epidemiology of wild poliovirus type 1 in Europe, the Middle East, and the Indian subcontinent. J Infect Dis 171:1399–1405
MuldersM. N.,
ReimerinkJ. H. J.,
StenvikM.,
AlaeddinogluI.,
van der AvoortH. G. A. M.,
HoviT.,
KoopmansM. P. G.1999; A Sabin vaccine-derived field isolate of poliovirus type 1 displaying aberrant phenotypic and genetic features, including a deletion in antigenic site 1. J Gen Virol 80:907–916
ReimerinkJ. H. J.,
van der AvoortH. G. A. M.,
van LoonA. M.,
KoopmansM. P. G.1999; Genetic basis for immunological aberrations in poliovirus Sabin serotype 3 strains imported in The Netherlands. J Clin Microbiol 37:2393–2398
StanwayG.,
CannA. J.,
HauptmannR.,
HughesP.,
ClarkeL. D.,
MountfordR. C.,
MinorP. D.,
SchildtG. C.,
AlmondJ. W.1983; The nucleotide sequence of poliovirus type 3 Leon 12 a1b: comparison with poliovirus type 1. Nucleic Acids Res 11:5629–5643